mediates proliferation and chloride secretion in ADPKD cystic renal epithelia. Am J Physiol Renal Physiol 303: F1425-F1434, 2012. First published August 29, 2012 doi:10.1152/ajprenal.00010.2012 contributes to cystogenesis in genetically nonorthologous models of autosomal dominant polycystic kidney disease (ADPKD). However, it remains unknown whether PGE 2 induces the classic features of cystic epithelia in genetically orthologous models of ADPKD. We hypothesized that, in ADPKD epithelia, PGE2 induces proliferation and chloride (Cl Ϫ ) secretion, two archetypal phenotypic features of ADPKD. To test this hypothesis, proliferation and Cl Ϫ secretion were measured in renal epithelial cells deficient in polycystin-1 (PC-1). PC-1-deficient cells increased in cell number (proliferated) faster than PC-1-replete cells, and this proliferative advantage was abrogated by cyclooxygenase inhibition, indicating a role for PGE2 in cell proliferation. Exogenous administration of PGE2 increased proliferation of PC-1-deficient cells by 38.8 Ϯ 5.2% (P Ͻ 0.05) but inhibited the growth of PC-1-replete control cells by 49.4 Ϯ 1.9% (P Ͻ 0.05). Next, we tested whether PGE2-specific E prostanoid (EP) receptor agonists induce intracellular cAMP and downstream -catenin activation. PGE 2 and EP4 receptor agonism (TCS 2510) increased intracellular cAMP concentration and the abundance of active -catenin in PC-1-deficient cells, suggesting a mechanism for PGE 2-mediated proliferation. Consistent with this hypothesis, antagonizing EP4 receptors reverted the growth advantage of PC-1-deficient cells, implicating a central role for the EP4 receptor in proliferation. To test whether PGE 2-dependent Cl Ϫ secretion is also enhanced in PC-1-deficient cells, we used an Ussing chamber to measure short-circuit current (I sc). Addition of PGE 2 induced a fivefold higher increase in Isc in PC-1-deficient cells compared with PC-1-replete cells. This PGE 2-induced increase in Isc in PC-1-deficient cells was blocked by CFTR-172 and flufenamic acid, indicating that PGE 2 activates CFTR and calcium-activated Cl Ϫ channels. In conclusion, PGE2 activates aberrant signaling pathways in PC-1-deficient epithelia that contribute to the proliferative and secretory phenotype characteristic of ADPKD and suggests a therapeutic role for PGE2 inhibition and EP4 receptor antagonism.prostanoid; secretory renal epithelia; cystic epithelia; cyclooxygenase THE IMPORTANCE OF PRECISE regulation of prostaglandin (PG) synthetic and signaling pathways is emphasized by the essential role of PGs in normal physiologic functions, such as the control of sodium (Na ϩ ) and water excretion in the renal collecting duct (CD), as well as in the contribution of PGs to pathologic conditions, such as colon cancer (7,12,38). Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive PKD are characterized histopathologically by a hyperproliferative cystic renal epithelium and clinically by polyuria (32). Recent observations suggest that altered prostanoid production contribut...